Skip to content

Axsome Therapeutics AXSM Proceeds From Issuance Of Common Stock Upon Exercise Of Options And Under Employee Stock Purchase Plan

Proceeds From Issuance Of Common Stock Upon Exercise Of Options And Under Employee Stock Purchase Plan at other companies

Applied Optoelectronics logo
Applied OptoelectronicsAAOI
$0+100%
Snap-on logo
Snap-onSNA
$30.6M+67.2%
Affirm Holdings, Inc. logo
Affirm Holdings, Inc.AFRM
$38.58M+267%
CoStar Group logo
CoStar GroupCSGP
$14M+100%
Clorox logo
CloroxCLX
-$2M-300%
IQVIA logo
IQVIAIQV
$16.75M+4.7%

Other financials

Income statement

See full
Revenue$191.2M+57.4%
Gross profit$176.5M+58.0%
Operating income-$63.4M-11.2%
Net income-$64.5M-8.6%
EPS (diluted)-$1.26-3.3%

Balance sheet

See full
Cash & equivalents$305.1M+1.4%
Total debt$219.9M+4.1%
Total equity$54.6M+2.6%
Total assets$713.6M+19.6%

Cash flow

See full
Operating cash flow-$20.7M+52.3%
CapEx$121.0K-64.2%
Free cash flow-$20.8M+52.4%

Valuation

See full
Market cap$12.89B+52.0%
Enterprise value$12.81B+52.9%
P/S18.2×-1.4×

Profitability

See full
Gross margin92.6%+1.1pp
Operating margin-24.4%-9.3pp
Net margin-26.6%-9.8pp
FCF margin-10.2%-3.9pp

Returns & leverage

See full
Return on equity-349.4%+109pp
Debt / equity+0.1×
Current ratio1.4×-0.6×

Where this comes from

Reported directly by Axsome Therapeutics in its filing.

Tagged under the XBRL concept axsm:ProceedsFromIssuanceOfCommonStockUponExerciseOfOptionsAndUnderEmployeeStockPurchasePlan.

The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axsome Therapeutics's proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axsome Therapeutics's proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan?
Axsome Therapeutics (AXSM) reported proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan of $9.98M in Q1 2026.
How has Axsome Therapeutics's proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan changed year-over-year?
Axsome Therapeutics's proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan decreased by 41.4% year-over-year, from $17.04M to $9.98M.
What does proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan mean?
Cash received from employees exercising their stock options or buying shares through company plans.
How do you interpret proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan?
Higher proceeds indicate increased employee participation in equity programs, often reflecting positive sentiment or high retention.
How does proceeds from issuance of common stock upon exercise of options and under employee stock purchase plan compare across companies?
Common across all public companies with equity-based compensation programs; varies based on stock price performance.